Karl G. Blume-Gerhard Schmidt Memorial Lecture in Transplantation Biology & Medicine
The annual City of Hope Celebration of Life Hematopoietic Cell Transplantation Reunion not only celebrates and commemorates survivors' lives, but also enables physicians and researchers to advance the science of hematopoietic cell transplantation, or HCT.
The Memorial Lecture, held in association with the annual HCT Reunion, commemorates the work and dedication of the late Gerhard Schmidt, M.D., who joined City of Hope's program in 1977 and established the Autologous Stem Cell Transplant and Histocompatibility Laboratory programs, among many other achievements. Schmidt lost his own battle with cancer in 1993.
In May 2013, hematology experts from around the country convened at City of Hope for the Blume-Schmidt Memorial Lecture in Transplantation Biology and Medicine to discuss the impact of Karl G. Blume, M.D., the founder of City of Hope's bone marrow transplant program. Blume launched the program in 1975, when such procedures were at the forefront of current science, and regarded as novelties in many circles. Today, that program is a world leader in hematopoietic cell transplantation.
The presenters and their topics:
Nelson J. Chao, M.D., M.B.A., chief of the Division of Cellular Therapy, Cell Therapy & Hematologic Malignancy Program at Duke University School of Medicine: “MicroRNAs as Biomarkers for GVHD.”
Robert S. Negrin, M.D., professor of medicine at Stanford University Medical Center: “GVHD from the Perspective of the T Cell.”
Frederick R. Appelbaum, M.D., member and director of the Clinical Research Division at Fred Hutchinson Cancer Research Center and professor and head of the Division of Medical Oncology: “Simpler and More Accurate Prognostic Testing in Acute Leukemia.”
John A. Zaia, M.D., Aaron D. Miller and Edith Miller Chair in Gene Therapy, chair and professor of the Department of Virology, and professor of pediatrics at City of Hope: “Blood Stem Cell Transplantation for HIV/AIDS: Is this the Future?”
Stephen J. Forman, M.D., Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation and chair of City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation: “T Cell Engineering to Improve the Graft Versus Leukemia Effect.”
Stephen J. Forman, M.D., chair of hematology and hematopoietic cell transplantation, shares his views on the essence of care at City of Hope. He highlights the bone marrow transplant program (BMT) and the program's growth over the years.
City of Hope's partnership with the Los Angeles Dodgers, includes ThinkCure!, an innovative, community-based non-profit that raises funds to accelerate collaborative research at City of Hope and Childrens Hospital Los Angeles to cure cancers.